ArticleDiabetology & metabolic syndrome2017

A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.

Hiroshi Nomoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.